MP60-11 EPIGENETIC INACTIVATION OF HOXA11 AS A NOVEL FUNCTIONAL TUMOR SUPPRESSOR FOR RENAL CELL CARCINOMA
wang lu,cui yun,jingdong sheng,guanyu kuang,yang yang,Fan Yu,Jin Jie,Zhang Qian
DOI: https://doi.org/10.1016/j.juro.2017.02.1848
2017-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II1 Apr 2017MP60-11 EPIGENETIC INACTIVATION OF HOXA11 AS A NOVEL FUNCTIONAL TUMOR SUPPRESSOR FOR RENAL CELL CARCINOMA wang lu, cui yun, jingdong sheng, guanyu kuang, yang yang, fan yu, jin jie, and zhang qian wang luwang lu More articles by this author , cui yuncui yun More articles by this author , jingdong shengjingdong sheng More articles by this author , guanyu kuangguanyu kuang More articles by this author , yang yangyang yang More articles by this author , fan yufan yu More articles by this author , jin jiejin jie More articles by this author , and zhang qianzhang qian More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1848AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES HOXA11 is a member of HOX transcription factors, the HOX genes encode transcription factors that play an essential role in regulating cell differentiation and proliferation. The hypermethylation of HOXA11 promoter region has been reported in various cancers. However, the epigenetic alteration and function of HOXA11 in human renal cell carcinoma (RCC) has not been explained. Therefore, to investigate the expression and function of HOXA11 is significant. METHODS PCR and IHC were used to check the expression of HOXA11 in RCC cells and tissues. To detect the methylation status of HOXA11 promoter, MSP (methylation specific PCR) and BGS (bisulfite genomic sequencing) were used. We also used colony formation, CCK8, wound healing, Transwell, Annexin V apoptosis assay and Western-blot to assess the function and related mechanism of HOXA11 in renal cell carcinoma. Finally, we used Fisher's exact test, Student's t test and Chi-square test to analyze the correlation between clinical features and HOXA11 promoter methylation. RESULTS HOXA11 was down-regulated by promoter aberrant methylation in both RCC cell lines and tissues compared with normal kidney cell line and tissues. HOXA11 methylation was found at higher prevalence (70.5%, 68/95) in human RCC tissues than in adjacent non-malignant renal tissues (13%, 3/23) and associated with higher TNM classification of RCC (p<0.05). In addition, restoration of HOXA11 expression reduced the proliferation, colony formation, migration and invasion abilities and induced RCC cells apoptosis. Moreover, HOXA11 was found to inhibit Wnt signaling. CONCLUSIONS Our study demonstrated that HOXA11 function as a tumor suppressor in RCC which is mainly regulated by epigenetics. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e794 Advertisement Copyright & Permissions© 2017MetricsAuthor Information wang lu More articles by this author cui yun More articles by this author jingdong sheng More articles by this author guanyu kuang More articles by this author yang yang More articles by this author fan yu More articles by this author jin jie More articles by this author zhang qian More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...